The paradigm for policy change is failing if the consequence is a fierce dispute between the negotiating parties leading to the removal of medicines from the PBS. It's certainly not a case study of a process working well.
If this is the outcome, then the approach is all wrong and needs to change
March 6, 2023 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
AI in healthcare and why doing nothing might be the biggest risk
February 5, 2026 - - Latest News -
An effective example of making the case for reform in a status quo-biased system
February 5, 2026 - - Latest News -
Pharmac consults on expanding access to Takeda blood cancer therapy
February 5, 2026 - - Latest News -
GBMA moves to reclaim the reform agenda with a focus on pricing and supply
February 5, 2026 - - Latest News -
Nuclear medicine sector argues for dedicated scheme to unlock cancer therapies
February 4, 2026 - - Latest News -
Pfizer’s once-monthly weight-loss injection delivers strong mid-stage results
February 4, 2026 - - Latest News -
GBMA Summit focuses on access, affordability and security in an uncertain world
February 4, 2026 - - Latest News

